ir.ptcbio.comInvestors | PTC Therapeutics, Inc.
ir.ptcbio.com Profile
Ir.ptcbio.com is a subdomain of ptcbio.com,
which was created on 2000-08-18,making it 24 years ago.
It has several subdomains, such as medhub.ptcbio.com , among others.
Description：The Investor Relations website contains information about PTC Therapeutics, Inc.'s business for stockholders, potential investors, and financial...
Discover ir.ptcbio.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.ptcbio.com Information
| HomePage size: 61.89 KB |
| Page Load Time: 0.733607 Seconds |
| Website IP Address: 204.237.221.178 |
ir.ptcbio.com Similar Website
| Maryland Real Estate Investors Association - Maryland Real Estate Investors Association |
| Viridian Therapeutics, Inc. - Investors & Media |
| Western Midstream - Investors - Investors |
| OMNOVA Solutions - Investors - Investors |
| PTC Inc. - Investor Relations |
| PTC Commissioners: Contacts |
| Investors | Marathon Oil Corporation - Investors |
| PTC/USER Portal : Homepage - PTC/USER - Support, Educate, Advocate |
| Axalta Coating Systems - Investors - Investors Overview |
| Investors | Horizon Therapeutics plc |
| Acorda Therapeutics Inc - Investors |
| Investors | Flexion Therapeutics, Inc. |
| Connected Investors | Connect With Real Estate Investors |
| Investors - Toromont Industries Ltd. - Investors |
ir.ptcbio.com PopUrls
| Investors | PTC Therapeutics, Inc. http://ir.ptcbio.com/ |
| Email Alerts - Unsubscribe - Investors | PTC Therapeutics, Inc. https://ir.ptcbio.com/unsubscribe |
| 0001104659-22-112002 | 8-K | iXBRL Viewer https://ir.ptcbio.com/node/15096/ixbrl-viewer |
| 0001070081-21-000007 | 8-K | iXBRL Viewer https://ir.ptcbio.com/node/13766/ixbrl-viewer |
| 8-K | iXBRL Viewer - Investors | PTC Therapeutics, Inc. https://ir.ptcbio.com/node/16366/ixbrl-viewer |
| 0001410578-19-001344 | 8-K | XBRL Viewer https://ir.ptcbio.com/node/12206/xbrl-viewer |
| 0001070081-23-000053 | 8-K | XBRL Viewer https://ir.ptcbio.com/node/16056/xbrl-viewer |
| 0001558370-21-004308 | 8-K | iXBRL Viewer https://ir.ptcbio.com/node/13851/ixbrl-viewer |
| Printed Materials | PTC Therapeutics, Inc. https://ir.ptcbio.com/printed-materials |
| Press Releases | PTC Therapeutics, Inc. https://ir.ptcbio.com/press-releases |
ir.ptcbio.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1593107644" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Thu, 25 Jun 2020 17:54:04 GMT |
| Link: http://ir.ptcbio.com/; rel="shortlink", http://ir.ptcbio.com/; rel="canonical", https://ir.ptcbio.com/investor-relations; rel="alternate"; hreflang="en", https://ir.ptcbio.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| Server: nginx |
| X-Age: 0 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-db9a3810-b70c-11ea-910e-dfdeae948a2a |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 11690 |
| X-EdgeConnect-MidMile-RTT: 5, 44 |
| X-EdgeConnect-Origin-MEX-Latency: 413, 413 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Thu, 25 Jun 2020 17:54:04 GMT |
| Date: Thu, 25 Jun 2020 17:54:04 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
ir.ptcbio.com Meta Info
| charset="utf-8"/ |
| content="PTC Therapeutics, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about PTC Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="https://ir.ptcbio.com/investor-relations" property="og:url"/ |
| content="Investors | PTC Therapeutics, Inc." property="og:title"/ |
| content="no-referrer" name="referrer"/ |
| content="The Investor Relations website contains information about PTC Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
ir.ptcbio.com Ip Information
| Ip Country: United States |
| City Name: Woodstock |
| Latitude: 39.3511 |
| Longitude: -76.8486 |
ir.ptcbio.com Html To Plain Text
PTC Therapeutics PTC Bio Toggle Menu About PTC About PTC Toggle Submenu Our Mission Our History Leadership Role of the Patient STRIVE Awards Program PRIORITY Program Contact Us Locations Therapeutic Focus Therapeutic Focus Toggle Submenu Approach Genetic Disorders Oncology Our Pipeline Our Pipeline Toggle Submenu Approved Medicines Areas of Interest Clinical Trials Investors Investors Toggle Submenu Press Releases Events & Presentations Corporate Governance Financial Information Annual Report and Proxy Stock Information Investor FAQs Contact Us Careers Careers Toggle Submenu Careers at PTC Our Benefits Our Culture Open Positions Search Investors Investors PTC Therapeutics, Inc. is committed to serving the interests of our shareholders. This part of our website includes corporate governance documents, press releases, financial information and other documents to help shareholders better understand who we are and what we do. Press Releases Jun 17, 2020 PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19 Jun 12, 2020 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View all press releases » Events & Presentations More events are coming soon. View all events & presentations » Data Provided by Refinitiv. Minimum 15 minutes delayed. Intra 3 mo. 6 mo. 1 yr. Widget - Stock Chart Investor Relations Investors Press Releases Events & Presentations Corporate Governance Financial Information Annual Report and Proxy Stock Information Investor FAQs Contact Us Shareholder Tools Shareholder Tools Printed Materials Email Alerts Downloads RSS Print Share Facebook LinkedIn Twitter RSS PTC Therapeutics About PTC Therapeutic Focus Our Pipeline Investors Careers Contact Us © 2019 PTC Therapeutics. All rights reserved. Terms of...
ir.ptcbio.com Whois
Domain Name: PTCBIO.COM Registry Domain ID: 33163803_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2023-08-14T05:15:10Z Creation Date: 2000-08-18T03:04:28Z Registry Expiry Date: 2024-08-18T03:04:28Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: DNS1.CSCDNS.NET Name Server: DNS2.CSCDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T14:08:23Z <<<